RADNOR, Pa., March 18, 2022 /PRNewswire/ NRx Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company, announced today that the company s Board of Directors appointed Ira Strassberg. | March 18, 2022
Remarks by Dr. Shmuel Yitzhaki, as published in Globes, an Israeli business newspaperBriLife vaccine may have better neurtralizing ability against Omicron.
Remarks by Dr. Shmuel Yitzhaki, as published in Globes, an Israeli business newspaperBriLife vaccine may have better neurtralizing ability against Omicron variant than first generation mRNA vaccines, according to IIBR
/PRNewswire/ NRx Pharmaceuticals (NRx) (Nasdaq: NRXP (or the "Company"), a Delaware corporation, today announced that it has closed its previously announced.